TruthFoundry News
Better tools. Better news.
Friday, September 4, 2026 · UTC
133 of 1624 in this edition
finance

Study: GLP-1 prescriptions for US children under 12 rose 300-fold since 2019

Study finds GLP-1 weight-loss drug prescriptions for US children under 12 rose from 0.03% in 2019 to 9.3% by June 2026.

TruthFoundry Desk
from the fact record
Share on X
Stands on 8 placed sources from 2 publishers.
As of 2026-09-04 19:13 UTC. Market figures are as the cited sources reported them at that time and may have moved since. This is news, not investment advice.
A study published in the journal Pediatrics reported that prescriptions for GLP-1 weight-loss drugs among U.S. children under 12 rose from 0.03% in 2019 to 9.3% as of June 2026, a more than 300-fold increase. [1] A major new study released today found that American children under 12 are now taking GLP-1 drugs to fight obesity at 300 times the rate of seven years ago. [2] Dr. Babak Orandi, lead investigator and obesity medicine specialist at NYU Langone Health, said that while absolute numbers of children under 12 receiving GLP-1 treatment are still low, GLP-1 use is accelerating rapidly and long-term safety monitoring is needed. [3] GLP-1 weight-loss drugs are not approved for use in children under 12, but clinical guidelines allow their use for obesity in children as young as 8 in certain cases. [4] The study analyzed data from more than 3.5 million U.S. children aged 8 to 11 with obesity but not diabetes. [5] General medical clinical guidelines allow the use of GLP-1 drugs in children as young as 8, even though it is not illegal for doctors to prescribe them to under-12s. [6] More than 20,000 children aged 8 to 11 have taken GLP-1 drugs since 2019, according to an analysis of 300 million electronic medical records. [7] The U.S. Food and Drug Administration does not currently approve any GLP-1 drugs for children under 12 years old. [8]
What this stands on
  1. A study published in the journal Pediatrics reported that prescriptions for GLP-1 weight-loss drugs among U.S. children under 12 rose from 0.03% in 2019 to 9.3% as of June 2026, a more than 300-fold increase. · Investing.com
  2. A major new study released today found that American children under 12 are now taking GLP-1 drugs to fight obesity at 300 times the rate of seven years ago. · The Independent
  3. Dr. Babak Orandi, lead investigator and obesity medicine specialist at NYU Langone Health, said that while absolute numbers of children under 12 receiving GLP-1 treatment are still low, GLP-1 use is accelerating rapidly and long-term safety monitoring is needed. · Investing.com
  4. GLP-1 weight-loss drugs are not approved for use in children under 12, but clinical guidelines allow their use for obesity in children as young as 8 in certain cases. · Investing.com
  5. The study analyzed data from more than 3.5 million U.S. children aged 8 to 11 with obesity but not diabetes. · Investing.com
  6. General medical clinical guidelines allow the use of GLP-1 drugs in children as young as 8, even though it is not illegal for doctors to prescribe them to under-12s. · The Independent
  7. More than 20,000 children aged 8 to 11 have taken GLP-1 drugs since 2019, according to an analysis of 300 million electronic medical records. · The Independent
  8. The U.S. Food and Drug Administration does not currently approve any GLP-1 drugs for children under 12 years old. · The Independent
We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.
Article provenance · 8 sources · v 001worldrecordwritingfiling

How this piece was made: written by TruthFoundry News Desk, a declared AI persona, at the working desk on Friday, September 4, 2026. Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.

1 · The world2 publishers reported the events
What they stated is the numbered source list above.
Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read. The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
The automated line wrote this as TruthFoundry News Desk using a large language model at 2026-09-05T00:35Z.
The prompts, verbatim
System instruction (the grounding rules)


The assignment: persona voice contract + this desk's standing instructions + the numbered facts



4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.


Integrity


Content hash (SHA-256)2ce6a27202330ce3538c6f5b18f14442be3a4ceaeafea3942634c9bcd707bce6


Hash basisheadline + dek + prose + the canonical citations JSON, exactly as filed


Receiptthis revision predates receipt-keeping; the filed row lives on the record


Machine readablethe full proof, JSON


Verify



A signature proves who filed this and that it has not changed since. It never makes a claim true.


Up next in this editionJudge declares mistrial in Lindsay Clancy triple-murder trial after jury deadlock